By Drug Target Review2026-01-05T10:16:00
Researchers in China have discovered a previously unknown mechanism that allows aggressive breast cancers to avoid immune attack, while simultaneously exposing a weakness that could make these tumours especially responsive to existing immunotherapy treatments.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-02-07T15:25:20
Sponsored by Bio-Techne
2023-07-11T16:13:06
Sponsored by Agilent
2023-03-03T14:06:14
Sponsored by Bio-Techne
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2023-05-10T11:18:16
Sponsored by Revvity
2023-06-13T13:30:40
Sponsored by NanoTemper Technologies
Site powered by Webvision Cloud